Richard Mountfield
General Counsel bei CONSTELLATION PHARMACEUTICALS, INC.
Ursprung des Netzwerks ersten Grades von Richard Mountfield
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 14 | |
Subsidiary | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Richard Mountfield
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Comptroller/Controller/Auditor | |
ZENTALIS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chairman | |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Chroma Therapeutics Ltd.
Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman | |
OCULAR THERAPEUTIX, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
The Trustees of Columbia University in The City of New York | College/University | Graduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree | |
MORPHOSYS AG | Biotechnology | Comptroller/Controller/Auditor | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Napp Pharmaceutical Holdings Ltd.
Napp Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Napp Pharmaceutical Holdings Ltd. develops and provides medicines to patients. It offers prescription products for respiratory diseases such as asthma, inflammatory conditions, Crohn's disease, ulcerative colitis, ankylosing spondylitis, rheumatoid arthritis and psoriasis, as well as pain management, blood cancers, and cardiovascular conditions. The company was founded on December 19, 1997 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Director of Finance/CFO | |
MorphoSys US, Inc. | Corporate Officer/Principal | ||
Stanford University | College/University | Graduate Degree | |
International Institute for Management Development | College/University | Masters Business Admin | |
University of Barcelona | College/University | Doctorate Degree | |
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Imperial College London | College/University | Undergraduate Degree | |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Vaderis Therapeutics AG
Vaderis Therapeutics AG BiotechnologyHealth Technology Vaderis Therapeutics AG is a clinical stage biotech company based in Basel, Switzerland. The Swiss company aims to develop medicinal treatments for rare and orphan diseases associated with vascular malformations. The company focuses on developing a medicine for the treatment of HHT and other diseases associated with vascular malformations. HHT is a rare disease that causes vascular overgrowth due to genetic mutations, and there are no drugs approved anywhere in the world that specifically treat it. The company was founded in 2019 by Nicholas Benedict, Pierre Saint-Mezard, and Damien Picard, and Nicholas Benedict has been the CEO since incorporation. Vaderis raised a series a financing from Medicxi and acquired a portfolio of allosteric Akt inhibitors from Almac Discovery Ltd. | Biotechnology | Chairman | |
Deaconess Medical Center | Corporate Officer/Principal | ||
University College London | College/University | Doctorate Degree | |
Janpix Holdings, Inc.
Janpix Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Janpix Holdings, Inc. engages in provision of research and experimental development on biotechnology. The company was founded by Patrick T. Gunning and Cortes Pierre and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member | |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Founder | |
Index Ventures SA
Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Analyst | |
AyurMaya Capital Management Co. LP
AyurMaya Capital Management Co. LP Investment ManagersFinance AyurMaya Capital Management Co. LP provides investment advice. The private company is based in Waltham, MA and has subsidiaries in United States. | Investment Managers | Private Equity Investor | |
Bardavon Health Innovations LLC
Bardavon Health Innovations LLC Data Processing ServicesTechnology Services Bardavon Health Innovations LLC provides data and analytics solutions. It offers note reporting, effort assessment, data analytics and application portals. The company was founded in 2004 and is headquartered in Overland Park, KS. | Data Processing Services | Director/Board Member | |
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Kalyra Pharmaceuticals, Inc.
Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Encoded Therapeutics, Inc.
Encoded Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Matrix Capital Management Co. LP
Matrix Capital Management Co. LP Investment ManagersFinance Matrix Capital Management Co. LP (Matrix) is an independent registered investment adviser and hedge fund manager headquartered in Waltham, Massachusetts. The firm was founded by David E. Goel and Paul J. Ferri in 1999. Matrix serves as the manager or management firm, as the case may be, with discretionary investment authority to private pooled investment vehicles, the securities of which are offered to investors on a private placement basis. | Investment Managers | Portfolio Manager-Equities | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
Instituto de Empresa SL | College/University | Masters Business Admin | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Other Consumer Services | Corporate Officer/Principal | |
AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Cambridge College | College/University | Graduate Degree | |
REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Colorado Health Sciences Center | College/University | Graduate Degree | |
Vanderbilt University | College/University | Graduate Degree | |
Hartwick College | College/University | Undergraduate Degree | |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA. | Medical/Nursing Services | Director of Finance/CFO | |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Public Communications Contact | |
Regis College | College/University | Undergraduate Degree | |
GYROSCOPE THERAPEUTICS HOLDINGS PLC | Biotechnology | Director/Board Member | |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chief Executive Officer | |
McMaster University | College/University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 33 |
Vereinigtes Königreich | 9 |
Schweiz | 5 |
Niederlande | 3 |
Spanien | 3 |
Sektoral
Health Technology | 21 |
Consumer Services | 17 |
Commercial Services | 6 |
Finance | 6 |
Technology Services | 2 |
Operativ
Director/Board Member | 83 |
Independent Dir/Board Member | 21 |
Corporate Officer/Principal | 21 |
Undergraduate Degree | 12 |
Chairman | 9 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Raj Bhikhu Parekh | 50 |
Sapna R. Srivastava | 21 |
David Johnson | 11 |
Karan Takhar | 11 |
Giovanni Mariggi | 9 |
Antony Mattessich | 8 |
Mark Plavsic | 7 |
Brenda J. Sousa | 7 |
Elisabet de los Pinos | 6 |
Lara Smith-Weber | 6 |
Julie Feder | 6 |
Carrie Murray | 5 |
Amy Elazzouzi | 5 |
Janet Hopkins | 5 |
Irina Apostolou | 4 |
- Börse
- Insiders
- Richard Mountfield
- Unternehmensverbindungen